Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Novartis
Center for International Blood and Marrow Transplant Research
Takeda
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Novartis
University of Alabama at Birmingham
University of Alabama at Birmingham
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Cogent Biosciences, Inc.
Masonic Cancer Center, University of Minnesota
University of Virginia
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
M.D. Anderson Cancer Center
New York Medical College
University of Nebraska
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Rush University Medical Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
IRCCS San Raffaele
Gruppo Italiano Malattie EMatologiche dell'Adulto
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Takeda
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Radboud University Medical Center
Masonic Cancer Center, University of Minnesota